Erkin Pekmezci

Dr. Erkin Pekmezci


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in International Journal of Trichology
Verified
Journal Article
Open access
PDF file
HGHilal Gökalp
Hilal Gökalp
EPErkin Pekmezci
Erkin Pekmezci
MTMurat Turkoğlu
Murat Turkoğlu
ZKZekayi Kutlubay
Zekayi Kutlubay
Introduction: Minoxidil has been used topically to stimulate hair growth for male androgenetic alopecia (AGA) for more than 3 decades. It is currently being used for female AGA and alopecia areata (AA) as well. Although much time has passed since its first use, our understanding of its mechanism of action is highly limited. Therefore, we examined the inflammatory properties of AGA and AA, two entities in which minoxidil is being used as a therapeutic agent. We investigated the in vitro expression levels of cytokine interleukin-1 alpha (IL-1α), a potent inhibitor of hair growth, in minoxidil-treated human keratinocyte (HaCaT) cells to determine whether this molecule exerts anti-inflammatory effects. Materials and Methods: Cellular proliferation was examined using the Cell Proliferation Kit II (XTT) reagent. After determining a noncytotoxic concentration, HaCaT cells were treated with minoxidil. RNA was isolated from both untreated and treated cells with TRI Reagent®. Expression of the IL-1α gene was determined by reverse transcription quantitative polymerase chain reaction analysis and is reported relative to glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which served as a control. Results: Results are presented as IL-1α/ GAPDH fold change. Minoxidil treatment downregulated IL-1α expression by 0.3433-fold compared with untreated cells (P = 0.001). Conclusion: This anti-inflammatory effect of minoxidil, as evidenced by significant downregulation of IL-1α gene expression in HaCaT cells, may represent one of its mechanisms of action in alopecia.

22 April 2017 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
MTMurat Türkoğlu
Murat Türkoğlu
EPErkin Pekmezci
Erkin Pekmezci
SKSongul Kilic
Songul Kilic
CDCihat Dundar
Cihat Dundar
HSHakan Sevinc
Hakan Sevinc

25 April 2019 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
GSGulbahar Sarac
Gulbahar Sarac
YKYelda Kapicioglu
Yelda Kapicioglu
SSSerpil Sener
Serpil Sener
IMIrem Mantar
Irem Mantar
SYSaim Yologlu
Saim Yologlu
EPErkin Pekmezci
Erkin Pekmezci

1 January 2018 in Medical Archives
Verified
Journal Article
Open access
EPErkin Pekmezci
Erkin Pekmezci
CDCihat Dundar
Cihat Dundar
MTMurat Turkoglu
Murat Turkoglu
Currently while, topical minoxidil and oral finasteride are the only medications approved in androgenetic alopecia (AGA), the cause oriented treatment and immunsupressive treatment are being performed in telogen effluvium (TE) and alopecia areata (AA) respectively. Considering the inflammatory factors in the pathogenesis of these three nonscarring alopecia forms, we have formulated a mixture for topical usage composed of six different herbal extracts (HE) which have already known antiinflammatory and antioxidant features. In addition to performing the phytochemical analysis of HE, we detected the gene expression level of IL-1α, the crucial hair loss mediator, for the putative efficacy in nonscarring alopecia. Cell proliferation assay was performed by XTT reagent. After determination of non-cytotoxic concentration, HaCaT cells were treated with HE. RNA isolations were carried out from both non-treated and treated cell groups by using TRI-reagent. Gene expressions of IL-1α and as control GAPDH were determined by RT-qPCR analysis. Results were represented as "IL-1α/GAPDH Fold Change". HE solution caused statistically significant downregulation of IL-1α gene expressions (p<0.0001), compared to untreated control cells. HE treatment ended up with 0.1900 fold change for IL-1α. IL-1α is a direct growth inhibitory agent in hair follicles and an important actor in the pathogenesis of AGA , TE, and AA. Considering together the vitamins, flavonoids, and trace elements identified in the phytochemical analyses and downregulation of IL-1α in HaCaT cells, our HE may be an auxiliary agent in the therapy of these three nonscarring alopecia forms.

24 December 1999 in International Journal of Cosmetic Science
Verified
Journal Article
Closed access
PDF file
MTM. Turkoglu
M. Turkoglu
EPErkin Pekmezci
Erkin Pekmezci
ASA. Sakr
A. Sakr

30 June 2018 in Records of Natural Products
Verified
Journal Article
Closed access
MTMurat Türkoğlu
Murat Türkoğlu
SKSongül Kılıç
Songül Kılıç
EPErkin Pekmezci
Erkin Pekmezci
MKMurat Kartal
Murat Kartal
Lepidium sativum L. (Brassicaceae) (Ls), garden cress, is an edible herb that is botanically related to watercress and mustard, sharing their peppery, tangy flavor and aroma. The various parts of the plant have been traditionally used for many respiratory, rheumatologic, cardiovasculary, metabolic, and gastrointestinal disorders. Several studies were performed showing its antiinflammatory, anticarcinogenic, antiproliferative as well as tissue protective effects. In all of these studies the positive effects of Ls were concluded as the result of its antioxidant features due to the polyphenols and organosulphur compounds. In this study, we investigated the molecular basis of antiinflammatory, antiproliferative, antimitotic and antiandrogenic effects of Ls leaf extract in HaCaT cells. The gene expression levels of vascular endothelial growth factor (VEGF), tumor necrosis factor-alpha (TNF-α), interleukin 1-alpha (IL-1α), and 5 alpha-reductase type II (SRD5A2) were studied. Gene expressions were determined by RT-qPCR analysis. Fold change results of the gene expression analyses showed that the plant extract caused statistically significant downregulation of VEGF (0.2167, p<0.0001), TNF-α (0.4133, p = 0.0262), and SRD5A2 (0.0567, p<0.0001). The fold change for IL-1α was 0.6900 and this result was not statistically significant (p = 0.1522). These preliminary results may partially explain the clinical success of Ls in the traditional medicine. Considering these results, topical application of Lepidium sativum extract may be beneficial for inflammatory, androgen dependent disorders of the skin.